CONMED, a medical technology company, completed the acquisition of Biorez, a medical device start-up, for $250m. “The addition of Biorez and its BioBrace platform represents an important step forward for our sports medicine portfolio. BioBrace fits seamlessly into our existing suite of products, and we are excited to advance the next generation of healing in sports medicine. BioBrace represents the type of high-growth, high-margin platform that drives our long-term vision for CONMED," Curt R. Hartman, CONMED Chair of the Board, President, and CEO.